Juha Aimo Koivurinta

Chief Executive Officer at Fibrogen Europe Oy

Health Technology

Profile

Juha Aimo Koivurinta is currently the Chief Executive Officer & Director at FibroGen Europe Oy since 2000.
He previously worked as a Director at AGC Biologics A.

Juha Aimo Koivurinta active positions

Companies	Position	Start
Fibrogen Europe Oy Fibrogen Europe Oy BiotechnologyHealth Technology Fibrogen Europe Oy develops and markets recombinant human collagens and gelatins for research purposes. It serves companies in the pharmaceutical, vaccine, medical device, diagnostic, industrial, food, cosmetic, and nutraceutical businesses. The company was founded on May 22, 1996 and is located at Helsinki, Finland.	Chief Executive Officer	31/03/2000

All active positions of Juha Aimo Koivurinta

Former positions of Juha Aimo Koivurinta

Companies	Position	End
AGC Biologics A/S AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark.	Director/Board Member	-

See the detail of Juha Aimo Koivurinta's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Juha Aimo Koivurinta's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
AGC Biologics A/S AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark.	Health Technology
Fibrogen Europe Oy Fibrogen Europe Oy BiotechnologyHealth Technology Fibrogen Europe Oy develops and markets recombinant human collagens and gelatins for research purposes. It serves companies in the pharmaceutical, vaccine, medical device, diagnostic, industrial, food, cosmetic, and nutraceutical businesses. The company was founded on May 22, 1996 and is located at Helsinki, Finland.	Health Technology